Renal function and effect of aminoglycoside therapy during the first ten days of life
Loading...
Date
Authors
Giapros, V. I.
Andronikou, S. K.
Cholevas, V. I.
Papadopoulou, Z. L.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
Pediatr Nephrol
Book name
Book series
Book edition
Alternative title / Subtitle
Description
The effect of aminoglycoside administration on kidney functional maturation was evaluated in groups of 30 preterm and 30 fullterm infants who were treated for 7 days because of suspected infection. One of three different aminoglycosides was administered to each subgroup of ten preterm and ten fullterm infants. Changes in tubular function in groups of ten preterm and ten fullterm infants who were not given antibiotics were also compared. The mean gestational age for preterm infants from 32.5 to 33.6 weeks and for fullterm infants between 39.2 and 39.5 weeks. The renal tubular function was assessed by examining the fractional excretion of sodium (FENa), potassium (FEK), phosphorus (FEP), magnesium (FEMg) and uric acid (FEUA) as well as by the urinary excretion of calcium as the calcium/creatinine (UCa/UCr) ratio. Gentamicin affected the normal plasma creatinine (PCr) decline in both treated groups (fullterm and preterm). Disturbances in FENa and UCa/UCr were more pronounced in treated preterm than in fullterm infants especially after netilmicin and gentamicin administration. FEMg was significantly affected in preterm infants treated with gentamicin. The findings of this study indicate that the effect of aminoglycosides on tubular function is dependent upon kidney maturity and the type of the aminoglycoside used for therapy.
Description
Keywords
Amikacin/adverse effects/therapeutic use, Aminoglycosides/*adverse effects, Anti-Bacterial Agents/*adverse effects/therapeutic use, Gentamicins/adverse effects/therapeutic use, Humans, Infant, Newborn, Infant, Premature, Infant, Premature, Diseases/*drug therapy, Infection/*drug therapy, Kidney/*drug effects/growth & development, Kidney Function Tests, Netilmicin/adverse effects/therapeutic use, Phosphorus/metabolism, Potassium/metabolism, Sodium/metabolism, Uric Acid/metabolism
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/12488990
http://www.springerlink.com/content/yv21qgancdgnyk6m/fulltext.pdf
http://www.springerlink.com/content/yv21qgancdgnyk6m/fulltext.pdf
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής